Patexia Research

Case number 2:19-cv-14731

Lawsuits

CELGENE CORPORATION v. CIPLA LIMITED > Summary

Court Case Number 2:19-cv-14731

Filing Date Jul 3, 2019

Termination Date Dec 14, 2020

Court New Jersey District Court

Status Judgment - Judgment on Consent

JudgesSusan D. Wigenton, Leda D. Wettre

Plaintiff

Defendant

Plaintiff Attorneys

17

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Brian Forsatz
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Anthony M. Insogna
Jones Day

Celgene
Attorney Name: Cary Miller
Jones Day

Bristol Myers Squibb
Attorney Name: Matthew J. Hertko
Jones Day

Celgene
Attorney Name: Evangeline L. Shih
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Gabriel P. Brier
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Hailey S. Verano
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Marta A. Godecki
Quinn Emanuel Urquhart & Sullivan

Celgene
Attorney Name: Uma N. Everett
Covington & Burling LLP

Defendant Attorneys

8

Cipla limited
Attorney Name: Lisa J. Rodriguez
Schnader Harrison Segal & Lewis LLP

Cipla limited
Attorney Name: Joshua I. Miller
Sterne, Kessler, Goldstein & Fox

Cipla limited
Attorney Name: Robert Stout
Sterne, Kessler, Goldstein & Fox

Cipla limited
Attorney Name: Sasha G. Rao
Sterne, Kessler, Goldstein & Fox

Cipla limited
Attorney Name: Paul A. Ainsworth
Sterne, Kessler, Goldstein & Fox

Cipla limited
Attorney Name: Robert C. Millonig
Sterne, Kessler, Goldstein & Fox

Cipla limited
Attorney Name: Josephine J. Kim
Sterne, Kessler, Goldstein & Fox

Cipla limited
Attorney Name: Sasha S. Rao
Sterne, Kessler, Goldstein & Fox

Counter Defendant

4

Celgene
Attorney Name: William C. Baton
Saul Ewing LLP

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP

Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP

Counter Claimant

Cipla limited
Attorney Name: Lisa J. Rodriguez
Schnader Harrison Segal & Lewis LLP

Cause

28:1338 Patent Infringement

Related Patents

Doc No	Title	Issue date
09101621	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation	Aug 11, 2015
09101622	Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone	Aug 11, 2015
09056120	Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine	Jun 16, 2015
08648095	Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor	Feb 11, 2014
08530498	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione	Sep 10, 2013
08431598	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Apr 30, 2013
08404717	Methods of treating myelodysplastic syndromes using lenalidomide	Mar 26, 2013
08193219	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Jun 5, 2012
07977357	Polymorphic forms of 3-(4-amino-1-oxo-1, 3 dihydro-isoindo1-2-yl)-piperidine-2,6-dione	Jul 12, 2011
07968569	Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione	Jun 28, 2011
07855217	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 21, 2010
07465800	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 16, 2008
07189740	Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes	Mar 13, 2007